PE anti-human CD90 (Thy1) Antibody
- 产品名称：
- PE anti-human CD90 (Thy1) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 328109
- 产品应用：
- 328109
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1608 |
1 |
- Verified Reactivity
- Human
- Reported Reactivity
- African Green, Baboon, Cynomolgus, Pigtailed Macaque, Rhesus, Pig
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- HEL cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Clone 5E10 recognizes an epitope on Thy-1 independent of its glycosylation, but is abolished under reducing conditions.4?Additional reported (for the relevant formats) applications include: immunohistochemical staining of acetone-fixed frozen sections, immunoprecipitation1, and immunofluorescence3.
- Application References
(PubMed link indicates BioLegend citation) -
- Craig W, et al. 1993. J. Exp. Med. 177:1331. (IP)
- Gundlach CW 4th, et al. 2011. Bioconjug. Chem. 22:1706. (Pig Reactivity)
- Touboul C, et al. 2013. J. Transl. Med. 11:28. (IF)
- Bradley JE, et al. 2013. Lab Invest. 93:365. (Epitope)
- Donnenberg VS, et al. 2010. Cytometry B. Clin. Cytom. 5:287. (IHC)
- Product Citations
-
- Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
- Park J, et al. 2021. Exp Ther Med. 22:808. PubMed
- Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed
- Liu C, et al. 2022. Regen Ther. 21:192. PubMed
- Kawai T, et al. 2015. Clin Cancer Res. 21: 3081 - 3091. PubMed
- Loegl J, et al. 2016. Reproduction. 152: 447 - 455. PubMed
- Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
- Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed
- Goodnough LH, et al. 2020. JBMR Plus. 4:e10398. PubMed
- Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed
- Yang J, et al. 2022. Cell Discov. 8:92. PubMed
- Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
- Branco MA, et al. 2020. Methods Mol Biol. . PubMed
- Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed
- Deng CC, et al. 2021. Nat Commun. 12:3709. PubMed
- Manresa MC, et al. 2020. Gastroenterology. 159:1778. PubMed
- Li C, et al. 2016. Cell Res. 10.1038/cr.2016.156. PubMed
- Adutler-Lieber S, et al. 2013. J Cardiovasc Pharmacol Therap. 18:78. PubMed
- Wu S, et al. 2020. Stem Cells Int. 2019:1515040. PubMed
- Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed
- Samuelson C, et al. 2021. Exp Hematol. 93:52. PubMed
- Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed
- Peterson CW, et al. 2022. Mol Ther Methods Clin Dev. 24:30. PubMed
- Santos J, et al. 2013. J Transl Med. 11:18. PubMed
- Wang H, et al. 2022. Hum Gene Ther. 33:389. PubMed
- Van Egeren D, et al. 2021. Cell Stem Cell. 28(3):514-523.e9. PubMed
- Osorio FG et al. 2018. Cell reports. 25(9):2308-2316 . PubMed
- Ambrosi TH, et al. 2020. Aging Cell. 19:e13164. PubMed
- Di Stefano B, et al. 2019. Cell Stem Cell. 25:622. PubMed
- Alexander TB, et al. 2018. Nature. 562:373. PubMed
- Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed
- Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
- Morris K, et al. 2014. PLoS One. 9:98656. PubMed
- Rabold K, et al. 2022. Nat Commun. 13:6149. PubMed
- Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed
- Lee JK, et al. 2021. Cells. 10:. PubMed
- Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
- Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
- Marozin S, et al. 2021. Sci Rep. 11:10933. PubMed
- Novak R, et al. 2022. Cell Death Dis. 13:820. PubMed
- Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed
- Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed
- Yasuda T, et al. 2021. Cell Reports. 34(8):108779. PubMed
- Neveu W, et al. 2015. Am J Physiol Cell Physiol. 309: C616 - C626. PubMed
- Sielatycka K, et al. 2017. Stem Cell Rev. 1.079166667. PubMed
- Wang X, et al. 2021. Inflammation. 44:1815. PubMed
- Khan SA, et al. 2021. Cell Reports. 35(11):109233. PubMed
- Zhao Y, et al. 2018. Stem Cell Reports. 10:509. PubMed
- Di Stefano B, et al. 2018. Nat Methods. 15:732. PubMed
- Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
- Ward D, et al. 2016. Haematologica. 101: 286 - 296. PubMed
- Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
- Bailey AL, et al. 2020. bioRxiv. . PubMed
- Rodriguez‐Meira A et al. 2019. Molecular cell. 73(6):1292-1305 . PubMed
- RRID
- AB_893442 (BioLegend Cat. No. 328109) AB_893433 (BioLegend Cat. No. 328110)
- Structure
- 25-35 kD glycoprotein, Ig superfamily
- Distribution
-
Subset of CD34+ hematopoietic stem cells, subset of fetal thymocytes, subset of fetal liver cells, fibroblast, activated endothelial cells, neurons and some leukemia cell lines
- Function
- Regulate hematopoiesis and neural cell growth, cell adhesion
- Ligand/Receptor
- β3 integrin, β2 integrin
- Cell Type
- Endothelial cells, Fibroblasts, Hematopoietic stem and progenitors, Leukemia, Mesenchymal Stem Cells, Neurons, Thymocytes
- Biology Area
- Immunology, Stem Cells
- Molecular Family
- CD Molecules
- Antigen References
-
1. McKenzie JL, et al. 1981. J. Immunol. 126:843.
2. Avalos AM, et al. 2002. Biol. Res. 35:231.
3. Wetzel A, et al. 2004. J. Immunol. 172:3850.
- Gene ID
- 7070 View all products for this Gene ID
- UniProt
- View information about CD90 on UniProt.org
